Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7SPO

Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4

7SPO の概要
エントリーDOI10.2210/pdb7spo/pdb
分子名称Spike protein S1, VNAR 3B4, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
機能のキーワードimmune system, viral protein-immune system complex, viral protein/immune system
由来する生物種Severe acute respiratory syndrome coronavirus 2
詳細
タンパク質・核酸の鎖数4
化学式量合計80797.89
構造登録者
Shi, K.,Aihara, H. (登録日: 2021-11-02, 公開日: 2022-01-05, 最終更新日: 2024-11-06)
主引用文献Ubah, O.C.,Lake, E.W.,Gunaratne, G.S.,Gallant, J.P.,Fernie, M.,Robertson, A.J.,Marchant, J.S.,Bold, T.D.,Langlois, R.A.,Matchett, W.E.,Thiede, J.M.,Shi, K.,Yin, L.,Moeller, N.H.,Banerjee, S.,Ferguson, L.,Kovaleva, M.,Porter, A.J.,Aihara, H.,LeBeau, A.M.,Barelle, C.J.
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography.
Nat Commun, 12:7325-7325, 2021
Cited by
PubMed Abstract: Single-domain Variable New Antigen Receptors (VNARs) from the immune system of sharks are the smallest naturally occurring binding domains found in nature. Possessing flexible paratopes that can recognize protein motifs inaccessible to classical antibodies, VNARs have yet to be exploited for the development of SARS-CoV-2 therapeutics. Here, we detail the identification of a series of VNARs from a VNAR phage display library screened against the SARS-CoV-2 receptor binding domain (RBD). The ability of the VNARs to neutralize pseudotype and authentic live SARS-CoV-2 virus rivalled or exceeded that of full-length immunoglobulins and other single-domain antibodies. Crystallographic analysis of two VNARs found that they recognized separate epitopes on the RBD and had distinctly different mechanisms of virus neutralization unique to VNARs. Structural and biochemical data suggest that VNARs would be effective therapeutic agents against emerging SARS-CoV-2 mutants, including the Delta variant, and coronaviruses across multiple phylogenetic lineages. This study highlights the utility of VNARs as effective therapeutics against coronaviruses and may serve as a critical milestone for nearing a paradigm shift of the greater biologic landscape.
PubMed: 34916516
DOI: 10.1038/s41467-021-27611-y
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.92 Å)
構造検証レポート
Validation report summary of 7spo
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon